carbostyril has been researched along with Primary Peritonitis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Al Rawy, MH; Bazeed, SES; El-Amir, MI; Ghweil, AA; Khodeary, A | 1 |
| Bruno, R; Fagiuoli, S; Lombardi, A; Zuccaro, V | 1 |
| Angeli, P; Bernardi, M | 1 |
| Ardolino, E; Patwardhan, VR; Wang, SS | 1 |
| Bon, D; Göttig, S; Herrmann, E; Hogardt, M; Kempf, VAJ; Kessel, J; Lange, CM; Mayer, A; Mücke, MM; Mücke, VT; Queck, A; Reinheimer, C; Rüschenbaum, S; Schwarzkopf, K; Vermehren, A; Vermehren, J; Weiler, N; Welker, MW; Zeuzem, S | 1 |
| Díaz-De-Alba, P; Docobo-Perez, F; Machuca, J; Ortiz, M; Pascual, Á; Recacha, E; Rodríguez-Martínez, JM | 1 |
| Fu, X; Jiang, J; Jing, C; Liu, L; Yin, Y; Zhang, X | 1 |
| Archimandritis, AJ; Cholongitas, E; Kontou-Kastellanou, C; Lahanas, A; Papatheodoridis, GV; Xanthaki, A | 1 |
| Garcia-Tsao, G; Ghassemi, S | 1 |
| Campillo, B; Dupeyron, C; Fouet, P; Leluan, G; Mangeney, N; Sedrati, L | 1 |
| Jansen, PL | 1 |
| Bauer, TM; Bory, F; Clemente, G; Follo, A; Navasa, M; Planas, R; Rodés, J; Vaquer, P; Vargas, V; Vila, J | 1 |
2 review(s) available for carbostyril and Primary Peritonitis
| Article | Year |
|---|---|
Prevention and treatment of infections in patients with cirrhosis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Humans; Liver Cirrhosis; Peritonitis; Quinolones | 2007 |
Spontaneous bacterial peritonitis. Detection, treatment and prophylaxis in patients with liver cirrhosis.
Topics: Antibiotic Prophylaxis; Ascites; Ascitic Fluid; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Liver Cirrhosis; Peritonitis; Prognosis; Quinolones | 1997 |
1 trial(s) available for carbostyril and Primary Peritonitis
| Article | Year |
|---|---|
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.
Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Quinolones; Secondary Prevention; Treatment Outcome | 2002 |
9 other study(ies) available for carbostyril and Primary Peritonitis
| Article | Year |
|---|---|
Fluoroquinolone-resistant strains in cirrhotic patients with spontaneous bacterial peritonitis: microbiological and molecular aspects.
Topics: Anti-Bacterial Agents; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Liver Cirrhosis; Microbial Sensitivity Tests; Mutation; Peritonitis; Quinolones | 2022 |
Prophylaxis of spontaneous bacterial peritonitis: Is there still room for quinolones?
Topics: Bacterial Infections; Humans; Liver Cirrhosis; Peritonitis; Quinolones | 2019 |
Reply to: "Prophylaxis of spontaneous bacterial peritonitis: is there still room for quinolones?"
Topics: Bacterial Infections; Humans; Liver Cirrhosis; Peritonitis; Quinolones | 2019 |
Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Boston; Ceftriaxone; Drug Resistance, Bacterial; Female; Humans; Length of Stay; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Quinolones; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Humans; Liver Cirrhosis; Peritonitis; Quinolones | 2020 |
Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Chromosomes, Bacterial; Ciprofloxacin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Norfloxacin; Peritonitis; Plasmids; Quinolones; Sepsis; Virulence | 2016 |
[Effects of Pseudomonas quinolone signal on the virulence of Pseudomonas aeruginosa].
Topics: ADP Ribose Transferases; Animals; Bacterial Adhesion; Bacterial Proteins; Bacterial Toxins; Cell Line; Humans; Male; Mice; Mice, Inbred BALB C; Peritonitis; Pseudomonas aeruginosa; Quinolones; Recombinant Fusion Proteins; Signal Transduction; Trans-Activators; Transcription, Genetic; Virulence | 2013 |
Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis.
Topics: Aged; Anti-Infective Agents; Ascites; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Quinolones | 2005 |
Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.
Topics: Ascites; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Liver Cirrhosis, Alcoholic; Microbial Sensitivity Tests; Norfloxacin; Peritonitis; Premedication; Quinolones | 1994 |